These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15280091)

  • 1. The perfusion paradox and vascular instability in sickle cell disease.
    Nath KA; Katusic ZS; Gladwin MT
    Microcirculation; 2004 Mar; 11(2):179-93. PubMed ID: 15280091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sickle red cell microrheology and sickle blood rheology.
    Ballas SK; Mohandas N
    Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
    Wood KC; Granger DN
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological insights in sickle cell disease.
    Odièvre MH; Verger E; Silva-Pinto AC; Elion J
    Indian J Med Res; 2011 Oct; 134(4):532-7. PubMed ID: 22089617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide transport on sickle cell hemoglobin: where does it bind?
    Gladwin MT; Ognibene FP; Shelhamer JH; Pease-Fye ME; Noguchi CT; Rodgers GP; Schechter AN
    Free Radic Res; 2001 Aug; 35(2):175-80. PubMed ID: 11697198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity.
    Bains SK; Foresti R; Howard J; Atwal S; Green CJ; Motterlini R
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):305-12. PubMed ID: 19965783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: effects of nitric oxide.
    Zuzak KJ; Gladwin MT; Cannon RO; Levin IW
    Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1183-9. PubMed ID: 12791593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
    Kaul DK; Liu XD; Chang HY; Nagel RL; Fabry ME
    J Clin Invest; 2004 Oct; 114(8):1136-45. PubMed ID: 15489961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.
    Hebbel RP
    Am J Hematol; 2011 Feb; 86(2):123-54. PubMed ID: 21264896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-dependent impairment of vascular function in sickle cell disease.
    Aslan M; Freeman BA
    Free Radic Biol Med; 2007 Dec; 43(11):1469-83. PubMed ID: 17964418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular adhesion and the endothelium: P-selectin.
    Kutlar A; Embury SH
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):323-39. PubMed ID: 24589269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease.
    Aslan M; Ryan TM; Adler B; Townes TM; Parks DA; Thompson JA; Tousson A; Gladwin MT; Patel RP; Tarpey MM; Batinic-Haberle I; White CR; Freeman BA
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15215-20. PubMed ID: 11752464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease and nitric oxide: a paradigm shift?
    Mack AK; Kato GJ
    Int J Biochem Cell Biol; 2006; 38(8):1237-43. PubMed ID: 16517208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
    Akinsheye I; Klings ES
    J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion.
    Frenette PS
    Microcirculation; 2004 Mar; 11(2):167-77. PubMed ID: 15280090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of living at moderate altitude on pulmonary vascular function and exercise capacity in mice with sickle cell anaemia.
    Ferguson SK; Redinius K; Yalamanoglu A; Harral JW; Hyen Baek J; Pak D; Loomis Z; Hassell D; Eigenberger P; Nozik-Grayck E; Nuss R; Hassell K; Stenmark KR; Buehler PW; Irwin DC
    J Physiol; 2019 Feb; 597(4):1073-1085. PubMed ID: 29931797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent and endothelium-independent vasodilatation of the cutaneous circulation in sickle cell disease.
    Mohan JS; Lip GY; Blann AD; Bareford D; Marshall JM
    Eur J Clin Invest; 2011 May; 41(5):546-51. PubMed ID: 21158851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease.
    Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ
    Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.